Author Archives: Scalper1

Red Hat (RHT) Beats Q3 Earnings and Revenue Estimates

Red Hat Inc.RHT reported third quarter fiscal 2016 adjusted earnings of 31 cents per share (including stock based compensation but excluding one time items), beating the Zacks Consensus Estimate of 30 cents. Earnings improved 3.3% on a year over

BioMarin, Intercept Pharma Drugs Face FDA Delays

BioMarin Pharmaceutical (BMRN) and Intercept Pharmaceuticals (ICPT) stocks were heading in opposite directions after both of their closely-watched drugs received delays in their FDA approval decisions. BioMarin’s Duchenne muscular dystrophy (DMD) treatment Kyndrisa (drisapersen) had a decision deadline, or PDUFA date, of Dec. 27, which meant that the news was widely expected to come by Christmas Eve. However, BioMarin said in a brief statement

Red Hat Stock Sets 15-Year Highs On Software Sales

Investors doffed their caps to Red Hat (RHT) Friday, pushing its stock to fresh 15-year highs after the company late Thursday provided Q3 earnings and sales that beat analyst expectations, as did its Q4 sales guidance. Red hot Red Hat stock gapped up 5.7% to 83.99 at the opening of the stock market today, eclipsing a Nov. 5 peak that hadn’t been seen since the 2000 dot-com bubble’s peak, shortly after Red Hat went public. Shares eased back later,